Skip to main content

Table 4 Unadjusted hospital mortality in patient subgroups

From: Glycaemic control in Australia and New Zealand before and after the NICE-SUGAR trial: a translational study

  Before NICE-SUGAR After NICE-SUGAR P
  n = 82,740 n = 93,765  
Medical patients* 19.8% (7,569) 18.5% (8,020) <0.0001
Surgical patients* 5.4% (2,345) 4.91% (2,427) 0.0008
IDDM patients* 13.9% (360) 11.86% (297) 0.029
No-IDDM patients* 12.07% (6,566) 10.93% (6,943) <0.0001
Patients with >48 h ICU stay* 16.58% (5,489) 15.32% (5,897) <0.0001
Patients with <48 h ICU stay* 9.06% (4,496) 8.32% (4,596) <0.0001
  1. *percentage (number of events). NICE-SUGAR, Normoglycemia in Intensive Care Evaluation and Surviving Using Glucose Algorithm Regulation.